PLAU and myeloid sarcoma: Some molecules linked with immune surveillance [C-X-C motif chemokine 16 (CXCL16) and interferon-gamma (IFN-γ)], urokinase-type plasminogen activator (uPA) and albumin were also found to be reduced in MS (Figures 2I–L).